Nifty
Sensex
:
:
18538.30
62392.05
25.55 (0.14%)
98.41 (0.16%)

Pharmaceuticals & Drugs

Rating :
69/99

BSE: 506879 | NSE: GUJTHEMIS

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,104.69
  • 20.70
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,092.34
  • 1.45%
  • 8.25

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 74.99%
  • 1.17%
  • 21.60%
  • FII
  • DII
  • Others
  • 0%
  • 0.02%
  • 2.22%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 15.01
  • 24.24
  • 10.50

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 31.91
  • 56.21
  • 12.77

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 44.89
  • 62.33
  • 22.60

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 14.48
  • 12.79
  • 13.56

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 6.73
  • 6.73
  • 6.73

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 10.15
  • 9.09
  • 9.83

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Jun 22
Jun 21
Var%
Mar 22
Mar 21
Var%
Dec 21
Dec 20
Var%
Sep 21
Sep 20
Var%
Net Sales
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Expenses
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBITDA
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBIDTM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Interest
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Depreciation
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PBT
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Tax
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PAT
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PATM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Top Investors:

News Update:


  • Gujarat Themis Biosyn reports 36% rise in Q2 net profit
    7th Nov 2022, 14:02 PM

    Total income of the company increased by 37.28% to Rs 49.09 crore for Q2FY23

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.